“Every Time I Go in There, It Gives Me Time to Reflect”: A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection - Top-Institutions - MDSpire

“Every Time I Go in There, It Gives Me Time to Reflect”: A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection

  • By

  • Thisara Jayasinghe

  • Mari-Lynn Drainoni

  • Alexander Walley

  • Christine Grella

  • Adam Majeski

  • Andrew Rolles

  • Ally Cogan

  • Guhan Venkatesan

  • Michael D Stein

  • Marc Larochelle

  • Jeffrey H Samet

  • Simeon D Kimmel

  • April 3, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Boston Medical Center
    Boston Medical Center

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Harm Reduction

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Harm Reduction

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Harm Reduction

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Addiction Medicine
    • Harm Reduction

Original Source(s)

“Every Time I Go in There, It Gives Me Time to Reflect”: A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection

  • by Thisara Jayasinghe, Mari-Lynn Drainoni, Alexander Walley, Christine Grella, Adam Majeski, Andrew Rolles, Ally Cogan, Guhan Venkatesan, Michael D Stein, Marc Larochelle, Jeffrey H Samet, Simeon D Kimmel

  • April 3, 2025

Related Content

Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey

Indiana community fights to keep needle exchange going after Trump order

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.